Stock Events

Stock Events

Bioporto AS 

kr0.95
15
+kr0.01+0.85% Today

Statistics

Day High
0.95
Day Low
0.95
52W High
2.63
52W Low
0
Volume
2,134
Avg. Volume
-
Mkt Cap
430.12M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

21MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.01
-0.01
-0.01
-0.01
Expected EPS
N/A
Actual EPS
N/A

Financials

-188.29%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
72.49MRevenue
-136.49MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0JJM.LSE. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap168.23B
Abbott Laboratories competes with BioPorto in the diagnostics and medical devices sector, particularly in areas related to kidney health and diagnostics.
Bio-Rad Laboratories
BIO
Mkt Cap8.07B
Bio-Rad Laboratories offers a range of products for the life science research and clinical diagnostics markets, overlapping with BioPorto's diagnostic solutions.
Danaher
DHR
Mkt Cap137.82B
Danaher Corporation operates in the diagnostics and research sector, directly competing with BioPorto in the development of diagnostic tests and products.
Thermo Fisher Scientific
TMO
Mkt Cap195.7B
Thermo Fisher Scientific provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, competing with BioPorto's offerings.
Becton Dickinson
BDX
Mkt Cap57.44B
Becton, Dickinson and Company competes in the medical technology sector, offering products for diagnostics, healthcare worker safety, and infection prevention that overlap with BioPorto's market.
Resmed
RMD
Mkt Cap33.3B
ResMed Inc. specializes in cloud-connectable medical devices for sleep apnea, COPD, and other chronic diseases, indirectly competing with BioPorto in the broader healthcare diagnostics market.
Hologic
HOLX
Mkt Cap16.97B
Hologic, Inc. focuses on diagnostics, medical imaging systems, and surgical products for women's health, competing with BioPorto in the diagnostics segment.
QuidelOrtho
QDEL
Mkt Cap865.32M
Quidel Corporation specializes in diagnostic healthcare solutions, including rapid diagnostic testing, competing directly with BioPorto's diagnostic products.
Guardant Health
GH
Mkt Cap11.85B
Guardant Health operates in the precision oncology field, offering liquid biopsy tests that, while focused on cancer, compete in the broader diagnostics market against BioPorto's solutions.

About

BioPorto A/S, an in-vitro diagnostics company, provides diagnostic tests and antibodies to clinicians and researchers worldwide. The company offers the neutrophil gelatinase-associated lipocalin test, a particle-enhanced turbidimetric test that measures NGAL that is used to supplement clinical evaluation and standard tests; monoclonal antibodies for scientific, pharmaceutical, and clinical research use; enzyme-linked immunosorbent assay kits; IVD automated assays; and generic rapid assay device platform for the development of lateral flow assays. It sells its products through own sales team, distributors, and OEM partnerships. The company was founded in 2000 and is headquartered in Hellerup, Denmark.
Show more...
CEO
Employees
28
Country
Denmark
ISIN
DK0011048619

Listings

OTC Link
US
THOXF
CO
DK
BIOPOR.CO
F
DE
2P4.F
LSE
GB
0JJM.LSE

0 Comments

Share your thoughts

FAQ

What is Bioporto AS stock price today?▼
The current price of 0JJM.LSE is kr0.95 DKK — it has increased by +0.85% in the past 24 hours. Watch Bioporto AS stock price performance more closely on the chart.
What is Bioporto AS stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bioporto AS stocks are traded under the ticker 0JJM.LSE.
What is Bioporto AS market cap?▼
Today Bioporto AS has the market capitalization of 430.12M
When is the next Bioporto AS earnings date?▼
Bioporto AS is going to release the next earnings report on May 21, 2026.
What is Bioporto AS revenue for the last year?▼
Bioporto AS revenue for the last year amounts to 72.49M DKK.
What is Bioporto AS net income for the last year?▼
0JJM.LSE net income for the last year is -136.49M DKK.
How many employees does Bioporto AS have?▼
As of April 24, 2026, the company has 28 employees.
In which sector is Bioporto AS located?▼
Bioporto AS operates in the Energy sector.
When did Bioporto AS complete a stock split?▼
Bioporto AS has not had any recent stock splits.